BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10068388)

  • 1. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control.
    Galgiani JN
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):293-300. PubMed ID: 10068388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coccidioidomycosis: a reemerging infectious disease.
    Kirkland TN; Fierer J
    Emerg Infect Dis; 1996; 2(3):192-9. PubMed ID: 8903229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combating opportunistic infections: coccidioidomycosis.
    Ampel NM
    Expert Opin Pharmacother; 2004 Feb; 5(2):255-61. PubMed ID: 14996623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species.
    Blair JE
    Curr Opin Infect Dis; 2008 Aug; 21(4):415-20. PubMed ID: 18594295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections.
    Blair JE
    Ann N Y Acad Sci; 2007 Sep; 1111():411-21. PubMed ID: 17332079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine against coccidioidomycosis is justified and attainable.
    Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
    Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of innate and adaptive immunity to coccidioidomycosis.
    Hung CY; Hsu AP; Holland SM; Fierer J
    Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary coccidioidomycosis.
    Thompson GR
    Semin Respir Crit Care Med; 2011 Dec; 32(6):754-63. PubMed ID: 22167403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area.
    Blair JE; Douglas DD; Mulligan DC
    Transpl Infect Dis; 2003 Mar; 5(1):3-8. PubMed ID: 12791068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coccidioidomycosis in elderly persons.
    Blair JE; Mayer AP; Currier J; Files JA; Wu Q
    Clin Infect Dis; 2008 Dec; 47(12):1513-8. PubMed ID: 18990061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coccidioidomycosis in liver transplant recipients relocating to an endemic area.
    Blair JE; Douglas DD
    Dig Dis Sci; 2004; 49(11-12):1981-5. PubMed ID: 15628738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Coccidioides serology in kidney transplant recipients: A 10-year cross-sectional analysis.
    Phonphok K; Beaird O; Duong T; Datta N; Schaenman J; Bunnapradist S
    Transpl Infect Dis; 2018 Oct; 20(5):e12932. PubMed ID: 29809303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coccidioidomycosis: Recent Updates.
    Twarog M; Thompson GR
    Semin Respir Crit Care Med; 2015 Oct; 36(5):746-55. PubMed ID: 26398540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area.
    Lohrmann GM; Vucicevic D; Lawrence R; Steidley DE; Scott RL; Kusne S; Blair JE
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28695649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coccidioidomycosis.
    Parish JM; Blair JE
    Mayo Clin Proc; 2008 Mar; 83(3):343-48; quiz 348-9. PubMed ID: 18316002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coccidioidomycosis.
    Stockamp NW; Thompson GR
    Infect Dis Clin North Am; 2016 Mar; 30(1):229-46. PubMed ID: 26739609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
    Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
    Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coccidioidomycosis in patients with various inflammatory disorders treated with tumor necrosis factor α inhibitors.
    Delafield NL; Mesbah Z; Lacy CR; Panicker RR; Pasha SF; Mertz LE; Yiannias JA; Blair JE
    Med Mycol; 2021 Jul; 59(7):720-727. PubMed ID: 33418569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioidomycosis.
    Powderly WG
    J Int Assoc Physicians AIDS Care; 1997 Mar; 3(3):38-40. PubMed ID: 11364125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.